These results suggested that adiponectin that was reduced in the ISFs in the AD brains of AD patients and APP/PS1 mice may be incapable of keeping CLSP sufficiently active in the presence of much higher concentrations of ApoE. This evidence concerns the gene APP and Alzheimer disease.